All News

As practitioners, advocating for our patients and managing common conditions to facilitate optimal pregnancy outcomes through preventative measures such as vaccination and addressing anemia have the potential for major impact.

Debate and discussion about the origin of the virus that causes COVID-19 have been at the forefront of the global consciousness since the first cases were reported in December 2019.

A significant uptick in telemedicine for managing diabetes in pregnancy occurred during the COVID-19 crisis, which should continue as the pandemic subsides, according to a session on telemedicine at the American Diabetes Association (ADA) virtual conference.

Results from one study found that many patients avoid going to the doctor because they feel uncomfortable seeking medical care or fear a serious illness. As providers, we need to recognize these issues and create a welcoming environment for all patients to ensure they don’t postpone care or avoid it entirely.

There are many reasons why a caregiver may refuse to have his or her child receive the human papillomavirus (HPV) vaccine, including safety concerns. A research letter examines whether those concerns have increased.

On June 2, 2021, ibrexafungerp (Brexafemme; Scynexis, Inc) was approved by the Food and Drug Administration for vulvovaginal candidiasis (VVC) in adult women and pediatric females who have begun menstruating. Ibrexafungerp is a triterpenoid antifungal that works by inhibiting the formation of the fungal cell wall. Ibrexafungerp (pronounced eye-BREX-ah-FUN-jerp) is the first approved drug of a novel class of antifungals.

In addition to welcoming a newborn, parents may be unexpectedly billed for some hospitalization services, according to a research letter in JAMA Health Forum.

Despite the umbilical artery (UA) Doppler pulsatility index being used to detect elevated fetoplacental vascular resistance, the metric is confounded by variation in fetal cardiac function and is only moderately predictive of placental pathology.

Scott Kober hosts this podcast in which he interviews Lisa Satterfield, senior director of health economics and practice management at the American College of Obstetricians and Gynecologists (ACOG). They discuss the tools and resources available to practicing ob-gyns that are focused specifically on payer and reimbursement issues.